These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15064612)

  • 1. Major histocompatibility gene therapy: the importance of haplotype and beta 2-microglobulin.
    Salamone FN; Gleich LL; Li YQ; Stambrook PJ
    Laryngoscope; 2004 Apr; 114(4):612-5. PubMed ID: 15064612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloantigen gene therapy for head and neck cancer: evaluation of animal models.
    Gleich LL; Li YQ; Li S; Gluckman JL; Stambrook PJ
    Head Neck; 2003 Apr; 25(4):274-9. PubMed ID: 12658731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for head and neck cancer.
    Gleich LL
    Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KITENIN increases invasion and migration of mouse squamous cancer cells and promotes pulmonary metastasis in a mouse squamous tumor model.
    Lee JK; Bae JA; Sun EG; Kim HD; Yoon TM; Kim K; Lee JH; Lim SC; Kim KK
    FEBS Lett; 2009 Feb; 583(4):711-7. PubMed ID: 19166844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer.
    Figueiredo ML; Kim Y; St John MA; Wong DT
    Clin Cancer Res; 2005 May; 11(10):3939-48. PubMed ID: 15897596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model.
    Sauter ER; Herlyn M; Liu SC; Litwin S; Ridge JA
    Clin Cancer Res; 2000 Feb; 6(2):654-60. PubMed ID: 10690551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma.
    O-Sullivan I; Kim TS; Chopra A; Cohen EP
    Anticancer Res; 2006; 26(2A):873-84. PubMed ID: 16619482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival.
    Siegele B; Cefalu C; Holm N; Sun G; Tubbs J; Meschonat C; Odaka Y; DeBenedetti A; Ghali GE; Chu Q; Mathis JM; Li BD
    J Surg Res; 2008 Jul; 148(1):83-9. PubMed ID: 18570935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of an orthotopic murine model of head and neck squamous cell carcinoma in fully immunocompetent mice--role of toll-like-receptor 4 expressed on host cells.
    Vahle AK; Kerem A; Oztürk E; Bankfalvi A; Lang S; Brandau S
    Cancer Lett; 2012 Apr; 317(2):199-206. PubMed ID: 22123294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cure of an established nonimmunogenic tumor, SCC VII, with a novel interleukin 12-based immunotherapy regimen in C3H mice.
    Mandpe AH; Tsung K; Norton JA
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):786-92. PubMed ID: 12874083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination surgery and nonviral interleukin 2 gene therapy for head and neck cancer.
    Li D; Jiang W; Bishop JS; Ralston R; O'Malley BW
    Clin Cancer Res; 1999 Jun; 5(6):1551-6. PubMed ID: 10389944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
    Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
    Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An optimum anti-melanoma response in mice immunized with fibroblasts transfected with DNA from mouse melanoma cells requires the expression of both syngeneic and allogeneic MHC-determinants.
    de Zoeten EF; Markovic D; Cohen EP
    Gene Ther; 2002 Sep; 9(17):1163-72. PubMed ID: 12170380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of cisplatin and overexpression of caspase-activated deoxyribonuclease (CAD) promotes apoptosis in vitro and in vivo.
    Kimura Y; Sugimoto C; Matsukawa S; Sunaga H; Igawa H; Yamamoto H; Ito T; Saito H; Fujieda S
    Oral Oncol; 2004 Apr; 40(4):390-9. PubMed ID: 14969818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7.
    Rubin J; Galanis E; Pitot HC; Richardson RL; Burch PA; Charboneau JW; Reading CC; Lewis BD; Stahl S; Akporiaye ET; Harris DT
    Gene Ther; 1997 May; 4(5):419-25. PubMed ID: 9274718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FasL gene therapy: a new therapeutic modality for head and neck cancer.
    ElOjeimy S; McKillop JC; El-Zawahry AM; Holman DH; Liu X; Schwartz DA; Day TA; Dong JY; Norris JS
    Cancer Gene Ther; 2006 Aug; 13(8):739-45. PubMed ID: 16543918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KITENIN represents a more aggressive phenotype in a murine model of oral cavity squamous carcinoma.
    Lee JK; Lim SC; Kim HD; Yoon TM; Kim K; Nam JH; Kim HS; Shin MH; Kim KK
    Otolaryngol Head Neck Surg; 2010 May; 142(5):747-52.e1-2. PubMed ID: 20416467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
    Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
    Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck.
    Gleich LL; Gluckman JL; Nemunaitis J; Suen JY; Hanna E; Wolf GT; Coltrera MD; Villaret DB; Wagman L; Castro D; Gapany M; Carroll W; Gillespie D; Selk LM
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):775-9. PubMed ID: 11448348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.